|
PREP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.284300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.811780E-04 |
| Normal-vs-Stage2 |
4.521700E-02 |
| Normal-vs-Stage3 |
1.859420E-01 |
| Normal-vs-Stage4 |
9.834300E-04 |
| Stage1-vs-Stage2 |
4.797200E-01 |
| Stage1-vs-Stage3 |
1.107400E-01 |
| Stage1-vs-Stage4 |
2.239800E-01 |
| Stage2-vs-Stage3 |
5.448600E-01 |
| Stage2-vs-Stage4 |
1.848760E-01 |
| Stage3-vs-Stage4 |
2.760200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.634000E-04 |
| Normal-vs-AfricanAmerican |
4.999900E-03 |
| Normal-vs-Asian |
2.836200E-01 |
| Caucasian-vs-AfricanAmerican |
9.704400E-01 |
| Caucasian-vs-Asian |
6.252400E-01 |
| AfricanAmerican-vs-Asian |
6.022000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.22670000000047E-05 |
| Normal-vs-Female |
4.542000E-01 |
| Male-vs-Female |
2.393800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.398100E-03 |
| Normal-vs-Extreme_Weight |
2.3100000001719E-07 |
| Normal-vs-Obese |
1.580340E-02 |
| Normal-vs-Extreme_Obese |
8.962300E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.419500E-02 |
| Normal_Weight-vs-Obese |
7.218200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.486800E-01 |
| Extreme_Weight-vs-Obese |
1.802350E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.969000E-01 |
| Obese-vs-Extreme_Obese |
4.492200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.406000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.621000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.579200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.385200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.892570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.828210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.754100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.242400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.322200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.195700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.55920000000687E-05 |
| Normal-VS-Type2 PRCC |
4.681300E-03 |
| Normal-VS-KIRP CIMP |
3.539200E-01 |
| Normal-VS-Unclassified PRCC |
1.227800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.631200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.820900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.150600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.469900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.926600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.914300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.411200E-04 |
| Normal-vs-N1 |
2.035600E-01 |
| Normal-vs-N2 |
6.777900E-03 |
| N0-vs-N1 |
5.681600E-02 |
| N0-vs-N2 |
3.564000E-01 |
| N1-vs-N2 |
7.720100E-02 |
|
|
